Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium
暂无分享,去创建一个
Pedro L. Teixeira | Henry J. Lin | K. Lunetta | M. Waldenberger | O. Franco | A. Uitterlinden | T. Lehtimäki | M. Chung | M. Rienstra | D. Chasman | V. Gudnason | P. Macfarlane | C. Albert | E. Benjamin | D. Conen | P. Ellinor | Albert Vernon Smith | B. Psaty | D. Roden | D. Arking | B. Stricker | O. Melander | K. Taylor | J. Rotter | W. März | J. Denny | T. Harris | N. Sotoodehnia | M. Müller-Nurasyid | E. Soliman | Xiuqing Guo | J. Jukema | A. Teumer | U. Völker | G. Engström | J. Smith | J. Bis | J. Barnard | M. Kähönen | L. Launer | D. V. Van Wagoner | S. Heckbert | S. Felix | L. Rose | Jie Yao | P. van der Harst | M. Kleber | L. Lyytikäinen | J. Jukema | G. Paré | M. Dörr | S. Lubitz | S. Trompet | G. Delgado | N. Verweij | I. Ford | K. Nikus | P. Weeke | Jonathan D. Smith | B. Geelhoed | B. Stricker | S. Thériault | S. Kääb | Á. Alonso | D. Klarin | M. Shoemaker | Moritz F. Sinner | B. Krijthe | L. Weng | J. Heeringa | I. Christophersen | P. L. Teixeira | P. Macfarlane | A. Martinsson | Stephan B. Felix | J. Yao | A. Smith | M. B. Shoemaker | P. van der harst | Jonathan D. Smith | Stephan B Felix | A. Smith | L. Rose | M. Kähönen | A. Uitterlinden | B. Psaty | Stephan B. Felix | J. G. Smith | K. Taylor | Peter Macfarlane | Á. Alonso | S. Felix
[1] Joshua C Denny,et al. Evaluating electronic health record data sources and algorithmic approaches to identify hypertensive individuals , 2017, J. Am. Medical Informatics Assoc..
[2] L. Køber,et al. Atrial fibrillation and risk of stroke: a nationwide cohort study. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[3] Ccfr and Gecco. Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer , 2016 .
[4] Stephanie A. Bien,et al. Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer , 2016, PLoS genetics.
[5] Hans L Hillege,et al. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands. , 2015, Journal of the American College of Cardiology.
[6] D. Roden,et al. Examining Rare and Low-Frequency Genetic Variants Previously Associated With Lone or Familial Forms of Atrial Fibrillation in an Electronic Medical Record System: A Cautionary Note , 2014, Circulation. Cardiovascular genetics.
[7] K. Lunetta,et al. Integrating Genetic, Transcriptional, and Functional Analyses to Identify 5 Novel Genes for Atrial Fibrillation , 2014, Circulation.
[8] D. Bluemke,et al. Diastolic function assessed from tagged MRI predicts heart failure and atrial fibrillation over an 8-year follow-up period: the multi-ethnic study of atherosclerosis. , 2014, European heart journal cardiovascular Imaging.
[9] K. Lunetta,et al. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. , 2014, Journal of the American College of Cardiology.
[10] M. Rich,et al. Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation. , 2013, The American journal of medicine.
[11] K. Lunetta,et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation , 2012, Nature Genetics.
[12] Ulrich Schotten,et al. PITX2c Is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression , 2011, Circulation. Cardiovascular genetics.
[13] Josée Dupuis,et al. Meta‐analysis of gene‐environment interaction: joint estimation of SNP and SNP × environment regression coefficients , 2011, Genetic epidemiology.
[14] Michael J Pencina,et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. , 2010, JAMA.
[15] Olle Melander,et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. , 2010, Journal of the American College of Cardiology.
[16] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[17] Randy L. Johnson,et al. Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification , 2010, Proceedings of the National Academy of Sciences.
[18] Thomas Meitinger,et al. Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation , 2010, Nature Genetics.
[19] E. Clayton,et al. Principles of Human Subjects Protections Applied in an Opt‐Out, De‐identified Biobank , 2010, Clinical and translational science.
[20] O. Melander,et al. Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity , 2010, European Journal of Epidemiology.
[21] C. Gieger,et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke , 2009, Nature Genetics.
[22] Jesper Hastrup Svendsen,et al. Familial Aggregation of Atrial Fibrillation: A Study in Danish Twins , 2009, Circulation. Arrhythmia and electrophysiology.
[23] Eric Boerwinkle,et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry , 2009, Nature Genetics.
[24] Elsayed Z Soliman,et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. , 2009, American heart journal.
[25] M. Banach,et al. Atrial Fibrillation: The New Epidemic of the Ageing World. , 2009, Journal of atrial fibrillation.
[26] Alberto Piazza,et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.
[27] G. Breithardt,et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[28] Thomas Meitinger,et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. , 2008, European heart journal.
[29] Monique M. B. Breteler,et al. The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.
[30] N. Cook,et al. Alcohol consumption and risk of incident atrial fibrillation in women. , 2008, JAMA.
[31] D. de Zeeuw,et al. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. , 2008, American journal of epidemiology.
[32] D. Roden,et al. Development of a Large‐Scale De‐Identified DNA Biobank to Enable Personalized Medicine , 2008, Clinical pharmacology and therapeutics.
[33] Randall J. Lee,et al. A first-degree family history in lone atrial fibrillation patients. , 2008, Heart rhythm.
[34] K. Kimura,et al. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[35] Michael D. Schneider,et al. Myocardial Pitx2 Differentially Regulates the Left Atrial Identity and Ventricular Asymmetric Remodeling Programs , 2008, Circulation research.
[36] V. Somers,et al. Atrial fibrillation and obesity--results of a meta-analysis. , 2008, American heart journal.
[37] N. Cook,et al. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. , 2008, Clinical chemistry.
[38] E. Benjamin,et al. Status of the epidemiology of atrial fibrillation. , 2008, The Medical clinics of North America.
[39] Richard P Harvey,et al. Pitx2c and Nkx2-5 Are Required for the Formation and Identity of the Pulmonary Myocardium , 2007, Circulation research.
[40] A. Hofman,et al. The Rotterdam Study: objectives and design update , 2007, European Journal of Epidemiology.
[41] Eric E. Smith,et al. Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.
[42] V. Gudnason,et al. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. , 2007, American journal of epidemiology.
[43] A. Hofman,et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.
[44] T. Lehtimäki,et al. The Finnish Cardiovascular Study (FINCAVAS): characterising patients with high risk of cardiovascular morbidity and mortality , 2006, BMC cardiovascular disorders.
[45] K. Stefánsson,et al. Familial aggregation of atrial fibrillation in Iceland. , 2006, European heart journal.
[46] J. Ruskin,et al. Familial aggregation in lone atrial fibrillation , 2005, Human Genetics.
[47] C. Gieger,et al. KORA-gen - Resource for Population Genetics, Controls and a Broad Spectrum of Disease Phenotypes , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).
[48] U. John,et al. Study of Health in Pomerania (SHIP): A health examination survey in an east German region: Objectives and design , 2005, Sozial- und Präventivmedizin.
[49] Ralph B D'Agostino,et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. , 2004, JAMA.
[50] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[51] W James Gauderman,et al. Sample size requirements for matched case‐control studies of gene–environment interaction , 2002, Statistics in medicine.
[52] M. Heo,et al. Resistance to change of adulthood body mass index , 2002, International Journal of Obesity.
[53] W. März,et al. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. , 2001, Pharmacogenomics.
[54] N. Cook,et al. Baseline characteristics of participants in the Women's Health Study. , 2000, Journal of women's health & gender-based medicine.
[55] P. Macfarlane,et al. The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. , 1999, The American journal of cardiology.
[56] P A Wolf,et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.
[57] F A Mathewson,et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.
[58] D. Levy,et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.
[59] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[60] Aric Invest. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .
[61] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[62] W. Kannel,et al. An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.
[63] T. Dawber,et al. Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.